§ 12-23-18-5.3 — Rules concerning opioid treatment

Indiana § 12-23-18-5.3

• Jurisdiction: Indiana
• Art. 23: ADDICTION SERVICES
• Ch. 18: Opioid Treatment Diversion Control and Oversight

Text

3. Subject to federal law and consistent with
standard medical practices in opioid treatment for substance abuse, the
division shall adopt rules under IC 4-22-2 concerning opioid treatment
by an opioid treatment provider, including the following:
(1) A requirement that the opioid treatment provider periodically
review with the patient the patient's treatment plan. In the review,
the opioid treatment provider shall consider changes to the plan
with the goal of requiring the minimal clinically necessary
medication dose, including, when appropriate, the goal of opioid
abstinence.
(2) Treatment protocols containing best practice guidelines for the
treatment of opiate dependent patients, including the following:
(A) Appropriate clinical use of all drugs approved by the
federal Food and Drug Administration for the treatment of
opioid addiction, including the following when available:
(i) Opioid maintenance.
(ii) Detoxification.
(iii) Overdose reversal.
(iv) Relapse prevention.
(v) Long acting, nonaddictive medication assisted treatment
medications.
(B) Requirement of initial and periodic behavioral health
assessments for each patient.
(C) Appropriate use of providing overdose reversal, relapse
prevention, counseling, and ancillary services.
(D) Transitioning off agonist and partial agonist therapies with
the goal, when appropriate, of opioid abstinence.
(E) Training and experience requirements for providers who
treat and manage opiate dependent patients.
(F) Requirement that a provider who prescribes opioid
medication for a patient periodically review INSPECT (as
defined in IC 25-26-24-7) concerning controlled substance
information for the patient.

Legislative History

As added by P.L.8-2016, SEC.4. Amended by P.L.51-2019, SEC.1.